Last updated on July 2020

Aflibercept for Retinopathy of Prematurity - Intravitreal Injection Versus Laser Therapy


Brief description of study

The purpose of this study is to demonstrate how well aflibercept works in babies with ROP, comparing it with laser therapy. The study also has the objective to demonstrate how safe aflibercept is when used in babies, and describe how the drug moves into, through and out of the body.

Clinical Study Identifier: NCT04004208

Find a site near you

Start Over

Unifesp/Epm

Sao Paulo, Brazil
  Connect »

Asan Medical Center

Seoul, Korea, Republic of
  Connect »

Samsung Medical Center

Seoul, Korea, Republic of
  Connect »

Hospital Kuala Lumpur

Kuala Lumpur, Malaysia
  Connect »

Pediatric Medical University

Saint-Petersburg, Russian Federation
  Connect »

City Children Hospital 1

Saint-Petersburg, Russian Federation
  Connect »

Hospital de Sant Joan de D u

Esplugues de LLobregat, Spain
  Connect »

Birmingham Womens Hospital

Birmingham, United Kingdom
  Connect »

Manchester Eye Hospital

Manchester, United Kingdom
  Connect »

Queen Mary Hospital

Hong Kong, Hong Kong
  Connect »

City Children Hospital 1

Saint-Petersburg, Russian Federation
  Connect »

Hospital de Sant Joan de D u

Esplugues de LLobregat, Spain
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.